Baxdrostat reduces the levels of a hormone that drives high blood pressure and could transform hypertension care.

Innovative spectral techniques in urine analysis provide rapid, precise diagnostics, transforming early disease detection and ...

Anemia along with renal tubular damage (RTD) is associated with all-cause mortality in the general population, suggesting it’s a novel risk factor that could enhance prognostic ...

Innovation in RNA-based, immunotherapy and targeted therapeutics is not just aspirational, it's urgently needed. Aggressive cancers such ...

A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the ...

The new drug, called BI 690517, works by targeting a hormone called aldosterone. This hormone helps the body control salt, ...

Scientists discovered that a gut bacteria molecule called corisin can travel to the kidneys, triggering inflammation and ...

The analysis of neural morphology across Heliconiini butterfly species revealed brain area-specific changes associated with new foraging behaviours. While the volume of the centre for learning and ...

Non-essential amino acids such as glutamine have been known to be required for T cell general activation through sustaining basic biosynthetic processes, including nucleotide biosynthesis, ATP ...

In a study, which findings have been published in the Journal of the American Medical Directors Association, the scoring ...

Baxdrostat, a selective aldosterone synthase inhibitor, lowered BP and albuminuria in patients with uncontrolled hypertension ...

Travere Therapeutics TVTX announced that the FDA, following further review of the supplemental new drug application (sNDA) ...